Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

118.61
+3.322.88%
Post-market: 118.610.00000.00%19:14 EDT
Volume:1.21M
Turnover:142.19M
Market Cap:17.36B
PE:10.61
High:118.77
Open:115.02
Low:114.66
Close:115.29
Loading ...

RBC Cuts Price Target on Biogen to $225 From $231, Keeps Outperform Rating

MT Newswires Live
·
13 Feb

Biogen price target lowered to $265 from $298 at Canaccord

TIPRANKS
·
13 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Vir Biotechnology (VIR) and Biogen (BIIB)

TIPRANKS
·
13 Feb

Biogen price target lowered to $140 from $165 at Wells Fargo

TIPRANKS
·
13 Feb

Biogen price target lowered to $145 from $160 at Citi

TIPRANKS
·
13 Feb

Biogen : Scotiabank Cuts Target Price to $224 From $244

THOMSON REUTERS
·
13 Feb

Cautious Outlook for Biogen Amid Revenue Decline and Market Challenges

TIPRANKS
·
13 Feb

Biogen : TD Cowen Cuts Target Price to $200 From $275

THOMSON REUTERS
·
13 Feb

Biogen Inc (BIIB) Q4 2024 Earnings Call Highlights: Strong EPS Growth Amid Revenue Challenges

GuruFocus.com
·
13 Feb

Biogen : RBC Cuts Target Price to $225 From $231

THOMSON REUTERS
·
13 Feb

Biogen : JP Morgan Cuts Target Price to $185 From $210

THOMSON REUTERS
·
13 Feb

Biogen : Truist Securities Cuts Target Price to $210 From $220

THOMSON REUTERS
·
13 Feb

Biogen price target lowered to $245 from $281 at Goldman Sachs

TIPRANKS
·
13 Feb

Dow, S&P 500 Fall After Consumer Inflation Report; Yields Rise

MT Newswires Live
·
13 Feb

US Equities Markets End Mixed Wednesday as CPI Accelerates

MT Newswires Live
·
13 Feb

Biogen Delivers Q4 Beat, Analyst Focuses On Leqembi Expansion, 2025 Outlook

Benzinga
·
13 Feb

Sector Update: Health Care Stocks Softer Wednesday Afternoon

MT Newswires Live
·
13 Feb

Biogen (BIIB) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
13 Feb

Biogen shares slump as multiple-sclerosis-drug sales disappoint

Dow Jones
·
13 Feb

Biogen Expects Decline in 2025 Revenue, Reports Fourth-Quarter Beat

MT Newswires
·
13 Feb